Literature DB >> 10564943

Summary of entire Japanese thorotrast follow-up study: updated 1998.

T Mori1, C Kido, K Fukutomi, Y Kato, S Hatakeyama, R Machinami, Y Ishikawa, T Kumatori, F Sasaki, Y Hirota, K Kiyosawa, S Hayashi, H Tanooka, T Sobue.   

Abstract

Updated data from two series in a cancer mortality study for a total of 412 Japanese Thorotrast patients were combined. The rate ratio for all deaths of Thorotrast patients, compared to controls, started to increase after a latent period of 20 years after injection of Thorotrast. Rate ratios for liver cancer, liver cirrhosis, leukemia and lung cancer were 35.9, 6.9, 12.5 and 2.0 times higher, respectively, than those for controls.

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10564943

Source DB:  PubMed          Journal:  Radiat Res        ISSN： 0033-7587            Impact factor:   2.841


  4 in total

1.  [Retention of contrast media in the history of radiology : Sequelae of the former use of thorotrast and new challenges].

Authors:  G van Kaick; S Delorme
Journal:  Radiologe       Date:  2016-12       Impact factor: 0.635

2.  First mortality analysis in the French cohort of uranium millers (F-Millers), period 1968-2013.

Authors:  Ségolène Bouet; Eric Samson; Iris Jovanovic; Dominique Laurier; Olivier Laurent
Journal:  Int Arch Occup Environ Health       Date:  2017-08-31       Impact factor: 3.015

Review 3.  The German Thorotrast Cohort Study: a review and how to get access to the data.

Authors:  B Grosche; M Birschwilks; H Wesch; A Kaul; G van Kaick
Journal:  Radiat Environ Biophys       Date:  2016-05-06       Impact factor: 1.925

4.  Transcriptomic analysis links hepatocellular carcinoma (HCC) in HZE ion irradiated mice to a human HCC subtype with favorable outcomes.

Authors:  Liang-Hao Ding; Yongjia Yu; Elijah F Edmondson; Michael M Weil; Laurentiu M Pop; Maureen McCarthy; Robert L Ullrich; Michael D Story
Journal:  Sci Rep       Date:  2021-07-07       Impact factor: 4.379
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.